New immune cell therapy tested for tough blood cancers
NCT ID NCT07447726
Summary
This early-stage study is testing a new type of CAR-T cell therapy for adults with large B-cell lymphoma that has come back or not responded to standard treatments. The main goals are to check the safety of the treatment and see if it helps shrink tumors. Only three participants will be enrolled to receive a single infusion of the modified immune cells and be closely monitored.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LARGE B-CELL LYMPHOMA (LBCL) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.